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Abstract
Disease processes that frequently require emergency care
constitute approximately 50% of the total disease burden
in low-income and middle-income countries (LMICs).
Many LMICs continue to deal with emergencies caused
by communicable disease states such as pneumonia,
diarrhoea, malaria and meningitis, while also experiencing
a marked increase in non-communicable diseases, such as
cardiovascular diseases, diabetes mellitus and trauma. For
many of these states, emergency care interventions have
been developed through research in high-income countries
(HICs) and advances in care have been achieved. However,
in LMICs, clinical research, especially interventional
trials, in emergency care are rare. Furthermore, there
exists minimal research on the emergency management
of diseases, which are rarely encountered in HICs but
impact the majority of LMIC populations. This paper
explores challenges in conducting clinical research in
patients with emergency conditions in LMICs, identifies
examples of successful clinical research and highlights the
system, individual and study design characteristics that
made such research possible in LMICs. Derived from the
available literature, a focused list of high impact research
considerations are put forth.

Background
The burden of critical illness and injury in
low-income and middle-income countries
(LMICs) is larger than in the higher-resource
settings.1 2 Research focused on improving
outcomes early in the presentation of acute,
potentially life-threatening or therapeutically
responsive disease processes could substantially reduce LMIC morbidity and mortality.
Emergency care clinical research has a significant role in such care transformations. The
goal of the Collaborative for Enhancing
Emergency Care Research in LMICs
(CLEER) project was to identify barriers to
clinical research in emergency care in LMICs,
propose solutions and recommend high
impact clinical research priorities that have
the potential to impact global public health.

Summary box
►► There is a paucity of high-quality research on the

emergency management of diseases, which are
rarely encountered in high-income countries (HICs)
but impact the majority of populations in low-income
and middle-income countries (LMICs).
►► Emergency care clinical research has substantial
potential to impact overall morbidity and mortality
in LMICs.
►► Addressable constraints to conducting clinical emergency care research in LMICs include: (1) lack of relevant and reproducible measures; (2) resource and
capacity barriers; (3) ethical constraints and (4) disconnect in recognised emergency care dimensions.
►► The following aspects should be considered to
conduct high-quality and relevant emergency care
clinical research in and for LMICs: (1) utilisation of
standardised, relevant and clinically credible measures; (2) focus on local capacity building, use of
technology and collaboration; (3) increased financial
and non-financial support must be prioritised; (4)
studies must focus on setting specific emergency
disease burdens and (5) translation of research findings into practice and policy through education and
engagement of local stakeholders is required.

Emergency department (ED) mortality in
LMICs is high, with mortality occurring in
1.8% (IQR 0.2%–5.1%) of overall cases and
4.8% (IQR 2.3%–8.4%) of paediatric cases.3
Injuries and infectious diseases4 contribute
the highest morbidity burden. Injury alone
accounts for ~5 million deaths annually; a
magnitude 1.7 times greater than the number
of fatalities from HIV, tuberculosis and malaria
combined.5 Sepsis, a common final pathway of
infectious diseases in life-threatening presentations, warrants special consideration in
LMICs which account for the majority of the
>30 million global cases annually.6 Additionally, initial presentations and complications of
non-communicable diseases such as diabetes
mellitus, hypertension and cerebrovascular
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disease are rising and will continue to increase health
burdens in LMICs.7 8 Continued and broadened research
in the resuscitation and management of injury, the early
recognition and treatment of infectious diseases and
complications of non-communicable diseases has potential to improve health outcomes in LMICs.
There are several constraints and barriers to this effort.
These include inadequate resources, lack of staff support
and underdeveloped research infrastructure for scientific
endeavours. Applying care guidelines from high-income
countries (HICs) to LMICs is constrained by insufficient
data and heterogeneity of resources and practice. Furthermore, LMIC patient populations are relatively young,
more often critically ill, and have higher age-matched
mortality than HIC emergency patients.3 The differences
in resources, organisation, epidemiology, and practice all
suggest that investment in research in LMICs will make
emergency care more effective, responsive, and appropriate for LMIC populations. Through improvements in
data collection and implementation of high-quality clinical studies, researchers in LMICs may develop cost-effective, disease specific and locally relevant interventions.
The focus of this paper is to identify challenges and
propose strategies for conducting clinical research in
LMICs, while highlighting key areas and implementation
considerations for future clinical research.
Emergency care research in LMICs: challenges and
strategies
Research metrics
Consistently applied, relevant and reproducible measures are required for emergency care research in LMICs
to demonstrate high impact and to improve practice both
locally and more broadly. The table 1 provides an overview of key data items with examples and issues germane
to LMIC research and emergency care. Additionally, to
help overcome barriers to high-quality systematised data
being gathered and maintained in LMICs factors inclusive of partnerships between academic institutions and
healthcare systems, material support for data collection
and linkage and incentives to overcome local opportunity costs would be beneficial.9 Specific to clinical interventional and observational studies, documented metrics
and measures should include structural and process
measures that complement clinical and patient level
outcome data.
Clinical outcomes
Clinical outcome measures vary according to study design
and intervention type. However, in-hospital mortality
is commonly collected as an objective, patient-centred
outcome measure. In addition to the initial ED resuscitation, in-hospital mortality may be affected by timing of
pre-ED interventions, post-ED care like surgical and critical care treatments. Due to the potential contribution
of these factors, research using in-hospital mortality must
take into account characteristics prior to ED presentation
2

as well as post-ED care delivery so that studies are able to
capture factors impacting outcomes across the continuum
of treatment. Furthermore, understanding ED-specific
mortality pertinent to the initial treatment period, especially through the first 24 hours of treatment, is an important and rarely reported outcome that is greatly needed
to inform and advance ED care provision. A common
mortality metric in research is 90-day mortality, but due to
resource limitations and barriers in many LMICs related
to communication mechanisms, geographic distance
and cultural practices, this commonly used outcome may
not be feasible and more proximate outcomes should be
used by LMIC researchers.10
In certain pathologies, mortality may be uncommon
and not be the most relevant research measure for
assessing emergency interventions.11 Thus, morbidity
metrics can be key outcome measures for emergency care
studies. Disability assessments and pragmatic evaluation
of pre-illness versus post-illness functionality, along with
abilities to perform social and vocational roles, should
be considered by researchers in LMICs where there is
limited information on such outcomes. Additionally, clinical process measures could serve as surrogate outcomes
of importance, by providing a dimension of understanding on resource availability and delivery.12 13 These
clinical process measures should be considered at the
outset of studies by LMIC emergency care researchers.
For instance, the ordering and actual administration of
intravenous fluid and blood products may be used as clinical process measures in acute resuscitation research.
Emergency care research in LMICs should collect
demographic, physiologic, laboratory and process
measures that are reproducible. To ensure that key data
are collected consistently and reliably, a parsimonious
minimum required data set should be ubiquitously used
with additional data gathered as needed, based on the
specific research question. These required minimum
data must include information regarding reasons for
presentation for emergency care and ED outcomes.12
Standardised clinical documentation forms, with uniform
sets of minimum variables, would help to facilitate data
consistency and acquisition. A smaller amount of data
collected with completeness and accuracy is more valuable than larger inaccurate and incomplete data collections. Establishing a standard reporting of these aspects
across LMIC ED research endeavours will facilitate
pooling of data and subsequently be a powerful repository to be able to better understand patient characteristics, disease burdens and outcomes within and across
LMIC ED settings.
Cost-effectiveness
Metrics on cost-effectiveness need to be collected in
research endeavours globally,13 especially in LMICs.
In relation to HIV and TB in LMICs, there exists data
on cost-effectiveness14; however, emergency care data is
sparse. Research on acute myocardial infarctions from
Latin America employing telemedicine referral pathways
Aluisio AR, et al. BMJ Glob Health 2019;4:e001289. doi:10.1136/bmjgh-2018-001289
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Table 1 Overview of metrics and considerations for use
Data Items

Examples

Issues

Facility

Prehospital
Facility (rural vs urban)

Different levels of data will be appropriate based
on facility and the research capacity

Personnel

Level of training
Proportion of providers across each levels of training

Large variability and must be thoroughly reported
to ensure understanding and generalisability of
findings

Equipment

CT scan, sterile equipment, basic disposable items, for
example, catheters, fluids, medications

Supply chain limitations and sustainability of
access

Setting

Demographics
Country demographics Age and sex distinctions with generally younger
populations with larger burdens of patients living with
minimal resources

Demographic and risk transitions are poorly
understood in LMICs and need to be well
documented

Comorbidities

Concurrence of infectious disease with non-infectious
ones (eg, burdens of anaemia in injured patients)
Chronic diseases often unrecognised in LMIC

Difficulty to assess and categorise for existence
and overlap

Prehospital care
ED
Admission as inpatient
Need for ICU
Discharge

ED length of stay
ED disposition
Inpatient length of stay
ICU availability and usage

Lack of clear definitions across physical structures
and within single facilities

Laboratory testing
Point of care testing

Blood counts
TuberculosiB or HIV tests
ECG
Ultrasound

Availability of tests and types
Documentation of results

Interventions for
treatments

Antimicrobials
Haemodynamic and respiratory support

Availability of equipment
Implementation costs

Implementation
Quality assurance

Uptake of and compliance with care algorithms

Difficult to maintain sustainability without resource
Need for simple evaluation points

ED based (initial treatment <24 hours)
In-hospital mortality and 30/60/90-day mortality

ED based outcomes not commonly collected
Posthospital follow-up difficult and resource
intensive

Processes

Outcomes
Mortality
Cause of death

Post-discharge function Quality of life and functionality assessments
and morbidity

Difficult to collect
Cultural appropriateness

Provider acceptability

Date from surveys, interviews, focus groups.

Poor uptake resulting in lack of representativeness
and inaccuracy
Uncommonly done in LMICs

Costing

Fees incurred, lengths of stay, ICU usage, treatments

Variability in costs across settings

ED, emergency department; ICU, intensive care unit; LMICs, low-income and middle-income countries.

to more well-resourced institutions has been shown to
be cost-effective and represents a collaborative methodology that could be used in other LMICs.15 Also previously studied in emergency care research in Uganda
is task shifting from more highly trained practitioners
to other providers with less training and this has been
found to have beneficial clinical impacts.16 Task shifting
has also been put forth as cost-effective in community
programmes for non-emergent health issues and study
in emergency care settings is warranted.17 Although cost
measurements are often difficult to attribute unless there
is a fee-for-service system of care, researchers should be
mindful of incorporating costing data into their work.
Until comprehensive data systems are widely in place, a
Aluisio AR, et al. BMJ Glob Health 2019;4:e001289. doi:10.1136/bmjgh-2018-001289

pragmatic approach in LMICs would be to use estimates
of resource usage, such as length of stay across care
venues, as well as medication administration, which in
aggregate will provide a functional approximation of cost
burden.
Human resource and infrastructure
Challenges in LMIC emergency care clinical research
are amplified by human resource and logistical and
infrastructural challenges.18 There are fewer trained
researchers per capita in LMICs versus HICs despite the
disproportionate disease burden. Additionally, academic
groups and researchers in LMICs often have less guidance from institutions, fewer mentorship resources and
3
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Box 1 Injury Care Research (Example of outcome
metrics)
Injuries affect approximately 1 billion people per year,leading to
over 5 million deaths and 138 million disability-adjusted life-years
annually. Over 90% of this burdenfalls on those living in LMICs,
where emergency andtrauma care resources are limited.5 35 36
Despite the highmorbidity and mortality, funding for, and execution
of, emergency care clinical research in LMICs has beenminimal.
However, an exemplary body of work in injuryscience derived from
the group implementing the CRASH trials does exist. This group runs
large international randomised controlled trials that use pragmatic
monitoring and data collection designs to evaluate large numbers
of injured patients with a deliberate inclusion of LMIC settings. The
Corticosteroid Randomisation After Significant Head Injury (CRASH)
1 trial randomised>10 000 patients to corticosteroid or placebo
after significant head injury and the Clinical Randomisation of an
Antifibrinolytic in Significant Haemorrhage (CRASH) 2 trial randomised
>20 000 patients to tranexamic acid or placebo after injury, both
evaluating short-term mortality outcomes.37 38 This body of work
highlights the role that appropriate and realistic outcome metrics
serve inperforming emergency care clinical trials in LMICs andhow
impactful results are attainable when comprehensiveresearch
platforms are utilised and integrated intothe provision of emergency
care.

less access to training to enhance research skills.19 20 In
LMICs, there are high rates of turnover and migration
of trained professionals, which inhibits longitudinal
development at instructional and national levels.21 Moreover, emergency care providers often treat patients with
high levels of severity and insufficient resources, further
inhibiting their abilities to focus time on designing and
performing clinical research.3
Capacity building in LMICs may be enhanced by
training of emergency care clinicians and researchers
in methods and logistical implementation appropriate
for their settings. Mentored research training that takes
into account cross-disciplinary and transgenerational
personnel interactions is a key component to building
research capacity in LMICs. Also important are developing a centralised institutional research agenda and
establishing leadership at institutions in LMICs that can
promote work at both system and individual levels and
contribute to focused scientific goals. As not all LMICs
can currently support such actions, collaboration either
regionally or globally with institutions able to support
education and mentoring of LMICs researches will be
beneficial. An example of a successful longitudinal initiative exists in Pakistan, where a collaborative research and
training programme with institutional buy-in for injury
prevention and treatment work has been developed and
produces not only high-quality emergency care research
but also an enhanced pool of local researchers and scientific outputs.22 23
Research ethics
Research ethics is of key importance in all medical
research and especially in LMIC emergency care
4

research where there is potentially limited protection for
patients due to less regulatory infrastructure and limited
guidance and oversight. This is further compounded by
the paucity personnel formally trained in ethical frameworks in many LMICs to support clinical trials and other
research activities.24 The ethical complexities are exacerbated by barriers to patient follow-up and the high
prevalence of vulnerable patients. Consequently, there
is a need for development of ethical review boards with
understanding of emergency care research in LMICs.
Such development will require local institutional investment to foster individual well-trained researchers and
more broadly research cultures, actions which could be
bolstered through partnerships between institutions with
existing systems to bridge the development of a strong
foundation in research ethics. Partnerships of this nature
would support promotion of emergency care research
training as highlighted above and provide protection to
the vulnerable patients needing acute emergency treatments.
Technology
Technology is frequently not utilised to its maximum
benefit to perform high=quality clinical emergency care
research in LMICs.13 Specifically, there tends to be less
comfort with and use of digital research data collection
in LMICs. In addition, health systems often have less
access to online resources and training programmes
either due to financial or technological constraints. The
provision of technological materials in LMIC settings to
enhance awareness, usability and implementation via
support from HIC partners and donors would assist in
overcoming these barriers.
Although these barriers exist, leveraging technology
represents a promising opportunity to improve emergency care research in LMICs. Tools such as tablet-based
data collection, text-based messaging for rapid follow-up
and telemedicine can assist with patient screening,
consent and enrolment and help streamline and standardise data collection and analysis leading to more
efficient manuscript production and dissemination.
Use of technology in training LMIC emergency care
researchers, including distance learning and non-traditional media, is a minimally studied but potentially
powerful area for development of human resources, as
research educators and institutions from HICs can be
strategically and efficiently utilised to train their counterparts in LMICs.25 Furthermore. partnering approaches
could have far-reaching magnitude as they could be replicated in multiple settings using the initially established
processes in an economically efficient manner.
Additionally, use of innovation in emergency care
research in LMICs could be better fostered through
engagement of diverse personnel and social media, as
has been demonstrated in medical hack-a-thons.26 Such
events in India, Pakistan and Uganda have generated
innovative ideas that have been used as launch pads for
internally and externally funded research projects.27
Aluisio AR, et al. BMJ Glob Health 2019;4:e001289. doi:10.1136/bmjgh-2018-001289
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Figure 1

Publications in emergency care clinical research by income strata over time.

These platforms are a novel model to support implementation of research that intersects with traditional and
non-traditional clinical research personnel and designs.
Financial support
Funding for emergency care research in LMICs is insufficient. Across major research funders globally between
2012 and 2016, there were only 115 supported projects for
emergency care research in Africa, four in South America
and 13 in Asia. This investment is compared with 1411
projects in North American countries funded during the
same time period.28 The minimal funding in emergency
care clinical research is mirrored in deficient publication
outputs from LMICs. As illustrated in figure 1, although
there is an increasing frequency in the global trend in
emergency care clinical research, the proportion occurring in LMICs is a small minority and has only comprised
2%–5% of published reports annually over the preceding
decade (Average=3.2%, ±SD: 0.9%), with an even smaller
proportion represented by clinical trials.
The disconnect between emergency health burdens
and support for clinical research and scholarly outputs
in LMICs illustrates the need for increased funding.29
Emergency medicine is a new specialty in most LMICs;
hence, it is difficult to identify local champions to engage
in grant funding applications, further lowering the
possibilities of securing research funding. To overcome
these challenges, partnerships with researchers that are
successful in securing funding should be developed with
emergency care researchers in LMICs. Such partnerships
could be with local, regional or international researchers
who work in research both within and external to emergency care provision, as the practice of emergency care
Aluisio AR, et al. BMJ Glob Health 2019;4:e001289. doi:10.1136/bmjgh-2018-001289

allows for study of diverse disease processes. Funding for
partnered research should include sources from conventional mechanisms and as well non-traditional sources
such as governmental organisations, non-governmental
organisations, device manufacturers, pharmaceuticals
and philanthropists. The dearth of funding must be
addressed in order to improve outcomes among some
of the most vulnerable and understudied populations
globally.
Key research focus areas
As outlined in table 2, emergency care research can be
characterised by the considerations of time, location
and priority syndromes and diseases. Emergency care in
LMICs differs from that in HICs in each of these dimensions, as a result of infrastructure, density of comprehensive care facilities and differing burden of disease
(including superimposed burden of communicable
and non-communicable diseases resulting from the risk
transition, eg, HIV infection complicating recovery in a
patient with severe injuries). Relative to higher resource
settings, initial illness presentation in LMICs tends to
occur later in the disease course and at clinics with fewer
resources than hospitals. Also, preclinical transport is
more frequently ad hoc without formalised medical
providers and support services, and care systems tend to
be fragmented both horizontally and vertically.30 31 Emergency care system development and capacity also tend to
be relatively constrained, often mirroring health system
development and capacity overall.
These considerations all factor into prioritisation
for clinical emergency care research in LMIC settings.
5
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Table 2 Dimensions of emergency care by resource setting
Emergency care Low resource
dimension
setting

Middle resource
setting

High resource
setting

Temporal

Relatively long time from illness onset to Variable time from illness onset to
Shorter time from illness
presentation for care; distribution skewed presentation for care; distribution with onset to presentation for care;
to right
long tails
distribution skewed to left

Spatial

Supermajority of initial illness presentation Variable presentations across health
to local acute intake areas of available
system, from local clinics to district
hospitals
health facilities with middle-level health
providers.

Supermajority of initial illness
presentations to hospital-based
emergency departments with
physician staff

Health burdens
and priorities

Substantial burden of disease related
to acute infectious disease, injuries,
high burden of paediatric illness; certain
settings may have unusually or uniquely
high prevalence of certain exposures or
conditions (eg, Ebola, extreme heat)

Variable range of threats across
settings; larger overall burden
of disease associated with noncommunicable and communicable
disease related to risk transition

Substantial proportion of
disease related to acute
exacerbations of chronic
disease

Variable skill and capacity, typically
concentrated in urban areas; variable
research capacity

Higher per capita rates of
physician coverage, relatively
high research capacity

System Capacity Lower average levels of training among
(clinical care and care providers, lower per capita provider
research)
rates, lower research capacity

Identifying priorities is context specific and depends
on disease burden (certain disease processes may be
more prevalent in specific areas such as HIV or Ebola
Virus Disease), resource availability and system structure, among others. There is wide variability, even
within specific LMICs, and this can further increase the
complexity of specific research prioritisation efforts. As
a result, in many LMIC settings, identifying and evaluating innovative ways to improve the systems and quality
of care are a crucial part of a broader research agenda.
Similarly, reducing barriers and constraints to accessing
care, which can be assessed using metrics such as time
between illness development and presentation for care, is
important, particularly in rural areas with disproportionately limited capacity. Overlaying assessment of access
and epidemiology of priority health threats in terms of
disease burden and amenability to intervention can help
guide infrastructure and research investment. In many
cases, emergency care research in LMICs has focused
on translation and implementation of practices deemed
efficacious in HICs to LMIC settings without taking into
account the appropriate systems and disease factors that
are present, as has been demonstrated in sepsis care in
Africa.32 33
In the majority of settings, emergency care of the
undifferentiated patient is driven by chief complaint and
syndromic presentations rather than pre-existing diagnoses. In LMIC settings, this approach has often resulted
in a focus on identifying syndromic presentations, which
de-emphasises the need for expensive and scarce laboratory and imaging services and promotes care directed by
common final pathological states (eg, immune dysregulation and shock), as these are responsible for the largest
burdens of morbidity and mortality in LMIC emergency
care settings.6 Moreover, these final common states may
lend themselves to treatment with simple and inexpensive bundled interventions, which can be taught to and
delivered by providers with limited but focused skills and
6

training.34 Priorities for choosing intervention bundles
are context specific and frequently chosen based on
pragmatic criteria for reducing morbidity and mortality
burdens and interaction with cost-effectiveness considerations (ie, interventions with a low number-needed-totreat and an appropriate cost-effectiveness estimate under
the constraints of the specific LMICs’ ability to support
Box 2 Sepsis Research in Africa (Example of key focus
area)
The emergency diagnosis and management of sepsis is an area
of LMIC research that has dimensions with unique characteristics
as compared with that in HICs and that could serve as a model for
research with crucial importance.39 Mortality due to sepsis is more
common in LMICs, and patients with sepsis often present to health
centreswith limited resources in advanced shock states. Additionally,
controlled trial data from Africa assessing the application of sepsis
treatments based on HIC protocols hasdemonstrated worse outcomes.
In a trial by Maitland etal, higher mortality in paediatric patients
with sepsis wasassociated with intravenous fluid bolus therapy.
Similarly,trial data among adult patients with sepsis from Zambia
found that protocol-based resuscitation with administration of
intravenous fluids and vasopressors were associated with a higher
in-hospital mortality compared withusual care.32 33 As such, research
aimed at identifying,triaging and treating patients with sepsis early
and appropriatelyis of high value. Such research could entail usingvital
signs or simple clinical assessments such as the QuickSepsisRelated Organ Failure Assessment score and integrating these with
accessible low-cost technology, suchas oxygen saturation monitoring,
to determine setting appropriate risk stratification algorithms.40 41
Subsequently,these pathways could be linked to context-appropriate
bundles of care which could be studied as an area of investigation
pertinent to patient-centred outcomes.Studies to identify patients with
infections who requireadmission versus those who can be managed
as outpatientsmay also ease the burden in the lower-resourcedED.
These questions could be approached using iterativestudy designs of
simple cohort studies followed by trialslooking at outcomes in LMIC
settings.
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the intervention). Accordingly, LMIC researchers and
funders of such research should adopt a framing paradigm, which focuses on the impact and cost-effectiveness
in the development, funding and execution of emergency care studies.
There is a paucity of implementation research, especially in emergency care from LMICs. Addressing this
data void will be fundamental to ensure the appropriateness and success of interventions moving forward. For
implementation studies, acceptability to practitioners
and patients should be a central focus along with feasibility based on existing resources in the specific LMIC
settings of interest. For acceptability evaluations, varying
approaches have been used including focus groups, electronic surveys and interviews. As such work is carried out,
cultural issues implicit in each approach should be taken
into consideration and leveraged to ensure the best
possible data are attained.
Conclusions
Emergency care clinical research has substantial
potential to impact overall morbidity and mortality in
LMICs. There are, however, addressable constraints to
conducting clinical research in LMICs including: (1)
lack of agreed on, relevant and reproducible measures;
(2) barriers in funding, resources, training and capacity;
(3) ethical constraints and (4) disconnect in recognised
emergency care dimensions.
In light of these challenges, the following approaches
should be considered when developing and conducting
high-quality emergency care clinical research in LMICs.
Utilisation of standardised outcome measures such as
mortality and the consistent collection of parsimonious
minimum data sets. Systematic incorporation of structural and human capacity development and the leveraging of technology and international collaborations to
catalyse development and improve equity in emergency
care research. Advocacy for funding from traditional and
non-traditional sources using collaborative partnership
should be strengthened. Research foci based on disease
burdens and syndromic presentations responsible for the
largest contributions to morbidity and mortality in emergency care settings must be prioritised. Research findings
from LMICs should be translated into practice and policy
through education and engagement of local stakeholders
which will support knowledge dissemination and integration into care delivery.
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